Detalhe da pesquisa
1.
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Br J Cancer
; 130(5): 861-868, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195887
2.
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.
Lancet Oncol
; 24(9): 1018-1028, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657461
3.
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gynecol Oncol
; 179: 123-130, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980767
4.
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet
; 397(10290): 2182-2193, 2021 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991479
5.
Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.
Anal Chem
; 94(27): 9540-9547, 2022 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767427
6.
Proteogenomics connects somatic mutations to signalling in breast cancer.
Nature
; 534(7605): 55-62, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27251275
7.
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.
Cancer
; 126(4): 725-736, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31714597
8.
Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations.
Gynecol Oncol
; 159(3): 804-810, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33012551
9.
Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutations.
Gynecol Oncol
; 157(2): 521-528, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145911
10.
Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Gynecol Oncol
; 158(2): 316-322, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561125
11.
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Br J Cancer
; 117(5): 619-627, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28742794
12.
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet
; 387(10022): 945-956, 2016 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26707054
13.
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.
Int J Gynecol Cancer
; 26(6): 1070-7, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27206285
14.
Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).
Mol Cell Proteomics
; 12(9): 2623-39, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23689285
15.
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma.
Thorax
; 69(10): 895-902, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25037982
16.
Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer.
Gynecol Oncol
; 135(3): 547-51, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25449569
17.
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.
BJOG
; 121 Suppl 7: 35-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488086
18.
Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.
Mol Cell Proteomics
; 11(6): M111.013854, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22199228
19.
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
J Ovarian Res
; 17(1): 71, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566237
20.
Normal Risk Ovarian Screening Study: 21-Year Update.
J Clin Oncol
; 42(10): 1102-1109, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194613